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Systematic molecular/genomic epidemiology studies 
for tuberculosis surveillance cannot be implemented in 
many countries. We selected Panama as a model for an 
alternative strategy. Mycobacterial interspersed repeti-
tive unit–variable-number tandem-repeat (MIRU-VNTR) 
analysis revealed a high proportion (50%) of Mycobacte-
rium tuberculosis isolates included in 6 clusters (A–F) in 
2 provinces (Panama and Colon). Cluster A correspond-
ed to the Beijing sublineage. Whole-genome sequencing 
(WGS) differentiated clusters due to active recent trans-
mission, with low single-nucleotide polymorphism–based 
diversity (cluster C), from clusters involving long-term 
prevalent strains with higher diversity (clusters A, B). Pro-
spective application in Panama of 3 tailored strain–spe-
cific PCRs targeting marker single-nucleotide polymor-
phisms identified from WGS data revealed that 31.4% of 
incident cases involved strains A–C and that the Beijing 
strain was highly represented and restricted mainly to 
Colon. Rational integration of MIRU-VNTR, WGS, and 
tailored strain–specific PCRs could be a new model for 
tuberculosis surveillance in countries without molecular/
genomic epidemiology programs.
Tuberculosis (TB) control depends on rapid diagnosis, efficient therapy, and control of transmission. New ge-
notyping strategies in Mycobacterium tuberculosis have led 
to development of molecular epidemiology strategies that 
enable clarification of TB transmission dynamics (1–3). 
PCR-based molecular epidemiology approaches, namely 
mycobacterial interspersed repetitive unit–variable-num-
ber tandem-repeat (MIRU-VNTR), are being replaced by 
genomic epidemiology approaches. These approaches are 
based on the identification of single-nucleotide polymor-
phisms (SNPs) using whole-genome sequencing (WGS), 
which offers higher discriminatory power and precision in 
assigning transmission clusters (4–6).
The national TB-control programs of many resource-
constrained countries with a high TB prevalence lack 
systematic molecular epidemiology analysis (7). These 
countries face insurmountable obstacles to availability of 
genomic epidemiology programs. Panama is an example 
of a country that, despite recently being classified in the 
upper-income category, has not implemented a systematic 
molecular/genomic epidemiology–based surveillance pro-
gram (7). The lack of such a program, together with other 
limitations, means that Panama now has the second highest 
incidence of TB in Central America and the highest TB 
death rate (8). The recent expansion of the Panama Canal 
has attracted migrants into the country, which probably 
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has affected host-country TB epidemiology, as reported in 
other settings (8–10).
The convergence of these circumstances made Panama 
ideal for evaluating an alternative simplified approach for 
optimized surveillance of TB transmission. We based our 
effort on a rational application of MIRU-VNTR, subsequent 
WGS analysis of clustered representatives, and final tailor-
ing of allele-specific oligonucleotide PCR (ASO-PCR) for 
local prospective targeted surveillance of TB cases.
Materials and Methods
Study Sample
The retrospective study sample comprised 94 M. tubercu-
losis isolates from diagnostic specimens of patients with 
symptomatic respiratory disease (excluding those under 
treatment) from 19 health centers and hospitals in Panama 
and Colon provinces in 2015. This convenience sample 
comprised 80 isolates from Panama and 14 from Colon. 
These 2 provinces provided 660 TB cases in 2015; thus, the 
convenience sample represented 14.4% of TB cases from 
that year. Among the 91 isolates with susceptibility data, 84 
(89.4%) were pansusceptible, 6 (6.4%) were monoresistant 
to isoniazid (2.1%) and rifampin (4.3%), and the remaining 
1 (1.1%) was multidrug-resistant (MDR) (Table). We also 
included additional prospective isolates from Colon and 
Panama (January–August 2018), selected following the 
same selection criteria as the retrospective strain collection.
Drug Susceptibility Testing
Drug susceptibility was determined at the National Tu-
berculosis Reference Laboratory in Gorgas Memorial 
Institute (Panama City, Panama) using GenoType MTB-
DRplus (Hain Lifescience, https://www.hain-lifescience.
de/en/). We confirmed drug susceptibility results by the 
proportion method on Löwenstein–Jensen medium against 
the first-line drugs isoniazid, rifampin, streptomycin, and 
ethambutol. Second-line resistance was not tested in this 
strain collection.
DNA Extraction
DNA was extracted from Löwenstein–Jensen cultures us-
ing double-distilled water protocols from the GenoType Kit 
(Hain Lifescience) for first-line drug susceptibility testing. 
DNA for MIRU-VNTR and WGS was extracted using the 
QIAamp DNA Mini Kit (QIAGEN, https://www.qiagen.
com) according to the manufacturer’s protocol or the cetyl 
trimethylammonium bromide–based standard purification.
MIRU-VNTR Analysis
We conducted genotyping using multiplex PCR based on 
24-locus MIRU-VNTR (11). DNA extraction and MIRU-
VNTR typing of the retrospective sample were performed 
at Instituto de Investigaciones Científicas y Servicios de 
Alta Tecnología Laboratories (City of Knowledge, Pana-
ma). PCR products were sized using capillary electropho-
resis in a 3130 Genetic Analyzer (Applied Biosystems, 
https://www.thermofisher.com). For the Beijing isolates, 
we added the 4 previously recommended additional hy-
pervariable locus set (1982, 3232, 3820, and 4120) to the 
24 loci MIRU-VNTR set (12). We assigned TB lineage 
and sublineages from MIRU-VNTR data using a lineage 
prediction tool (TBminer, http://info-demo.lirmm.fr/ 
TBminer) (13).
WGS
WGS was performed in Hospital Gregorio Marañón 
(Madrid, Spain) as detailed elsewhere (14) on 2–3 rep-
resentative isolates of each cluster. We generated DNA 
libraries following the Nextera XT Illumina protocol 
(Nextera XT Library Prep kit [FC-131–1024]; Illumi-
na, https://www.illumina.com). Libraries were run in a 
MiSeq device (Illumina) by applying a paired-end read-
ing procedure. We mapped the reads for each strain by 
using the ancestral M. tuberculosis complex genome, 
which was identical to H37Rv in terms of structure 
 
Table. Study population, drug resistance, and genotypes of 




 Panama, n = 80 80 (85) 
 Colon, n = 14 14 (15) 
Antimicrobial drug susceptibility 
 
 Susceptible 84 (89.4) 
 Monoresistant 6 (6.4) 
 Isoniazid  2 (2.1) 
 Rifampin 4 (4.3) 
 Multidrug-resistant 1 (1.1) 
 No data 3 (3.2) 
Lineage/sublineage 
 
 Lineage 1 3 
  East African Indian  3 
 Lineage 2 7 
  Beijing 7 
 Lineage 4 82 
  Latin-American-Mediterranean 31 
  Haarlem 28 
  H37Rv-like 18 
  Cameroon 3 
  X 2 
 Lineage 5 1 
  West_African_1 1 
 Lineage 6 1 
  West_African_2 1 
Distribution of clustered isolates 
 
 Cluster A (Beijing) 7 (15) 
 Cluster B (Haarlem)† 14 (30) 
 Cluster C Latin-American-Mediterranean† 9 (19) 
 Cluster D (H37Rv-like) 12 (26) 
 Cluster E Latin-American-Mediterranean† 3 (6) 
 Cluster F (H37Rv-like) 2 (4) 
*Values are no. (%) isolates or % isolates. 
†One strain of this cluster was monoresistant to rifampin. 
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but with the ancestral alleles inferred by using a max-
imum-likelihood approach (15). SNP calls were made 
with SAMtools (http://samtools.sourceforge.net/) and 
VarScan (http://varscan.sourceforge.net/) (coverage 
of at least 20-fold, mean SNP mapping quality of 20) 
(14,16). From the variants detected, we kept only the 
homozygous calls (those present at a specific position 
in >90% of the reads). Moreover, to filter out poten-
tial false-positive SNPs attributable to mapping errors, 
we omitted the variants detected in repetitive regions, 
phages, and Pro-Glu (PE)– and Pro-Pro-Glu (PPE)–rich 
regions. In addition, we omitted SNPs close to inser-
tion/deletions (10-bp window) and those in areas with 
an anomalous accumulation of variants (>3 SNPs in 10 
bp). Alignments and SNP variants were visualized and 
checked in IGV version 2.3.59 (http://software.broadin-
stitute.org/software/igv). A cutoff of <12 SNPs was used 
to consider 2 isolates as clustered due to recent trans-
mission, as defined in Walker et al. (6). We deposited 
the sequences obtained in EMBL-EBI (http://www.ebi.
ac.uk [accession nos. PRJEB23681 and PRJEB29408] 
and http://bioinfo.indicasat.org.pa).
Design of ASO-PCR
For MIRU-VNTR–defined clusters A, B, and C, we 
identified the strain-specific SNPs after comparing WGS 
data with a database containing 4,598 sequence genomes 
from strains circulating throughout the world (A. Chiner-
Oms, unpub. data). We selected 3 strain-specific SNPs 
for cluster A and 4 for clusters B and C to be targeted 
by a multiplex ASO-PCR (Appendix Table 1, https://
wwwnc.cdc.gov/EID/article/25/3/18-1593-App1.pdf). 
We designed these ASO-PCRs to ensure the presence of 
amplification patterns, regardless of the strain analyzed. 
For cluster A, we designed 1 selective primer (SNP2) to 
target the allele found in the cluster A strain, whereas 
the 2 remaining primers (SNP1 and SNP3) targeted the 
alternative alleles, as expected in any other non-A strain. 
For clusters B and C, 2 primers (SNP1/SNP4 and SNP3/
SNP4, respectively) targeted the alleles found in strains 
B and C, whereas the remaining SNPs targeted the alter-
native alleles. The size of the amplicons was calculated 
to rule out overlap and led to different band patterns in 
each case (Appendix Table 1). We fixed the final PCR 
protocols (Appendix Tables 1, 2) after evaluating mul-
tiple experimental conditions until the expected patterns 
for the strains surveyed and a set of different control 
strains were confirmed.
The ASO-PCR design and optimization were conduct-
ed in Hospital General Universitario Gregorio Marañón 
(Madrid, Spain). The data were transferred to be applied at 
the National Tuberculosis Reference Laboratory in Gorgas 
Memorial Institute in Panama City.
Results
MIRU-VNTR–Based Cluster Analysis
In MIRU-VNTR analysis, 47 (50.0%) of the M. tuber-
culosis retrospective isolates from Panama and Colon 
provinces grouped into 6 clusters, A–F. Four clusters 
(A–D) comprised 7–14 isolates each; the remaining 2 
were smaller (E, 3 isolates, and F, 2 isolates) (Appendix 
Figure). Most (87%) isolates corresponded to lineage 4; 
7.4% corresponded to lineage 2. Sublineages for the larg-
est clusters corresponded to Beijing (cluster A) and Haar-
lem (cluster B), Latin-American-Mediterranean (cluster 
C), and H37Rv-like (cluster D) (Table). Clusters A and 
F consisted mostly of cases from Colon; the remaining 4 
clusters consisted mostly of cases from Panama. Clusters 
A, D, and F corresponded exclusively to pansusceptible 
strains; clusters B, C, and E each included 1 isolate that 
was monoresistant to rifampin.
WGS Analysis
Representative isolates (2 each from clusters A and B 
and 3 from cluster C) were available for a more in-depth 
analysis by WGS in Madrid, Spain. The sequences ob-
tained offered a depth of coverage of 20×–55×, with a 
Phred score >20. The short pairwise distances (1–3 
SNPs) for cluster C were consistent with recent trans-
mission. However, 19 SNPs were found between the iso-
lates in cluster A, and 20 SNPs were found between the 
isolates in cluster B, which was more consistent with the 
higher diversity expected for clusters involving long-
term prevalent strains.
ASO-PCRs for Targeted Surveillance  
of Selected Clusters
Once we identified the coexistence of 1 cluster due to 
active recent transmission with 2 clusters that were 
more likely to be prevalent, ASO-PCRs were designed 
in Madrid with 2 objectives: 1) prioritize the targeted 
surveillance of the actively transmitted cluster C; and 2) 
facilitate capture of new cases involved in clusters A and 
B with the aim of completing the phylogenetic recon-
struction of long-term clusters. We designed 3 multiplex 
ASO-PCRs to target 3 SNPs for cluster A, 4 for cluster 
B, and 4 for cluster C (Appendix Tables 1, 2). We used 
all representatives for clusters A and C and 12 of 14 of 
those in cluster B as positive controls, and we detected 
the expected amplification patterns. Forty-nine Beijing 
isolates other than A strain, 46 Haarlem isolates other 
than B strain, and 36 Latin-American-Mediterranean 
isolates other than C strain were also used as negative 
controls of the strains targeted. In all cases, the expected 
patterns were obtained for the non–A–C control isolates 
(Figure 1).
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Prospective Implementation of the  
ASO-PCR–Based Strategy
We used 51 prospective isolates from Colon and Panama 
collected during 2018 to evaluate the performance in situ of 
the 3 sets of cluster A–C–specific ASO-PCRs. The amplifi-
cation patterns obtained in Madrid in the optimization step 
were now reproduced exactly in Panama. Cluster A PCR 
revealed 13 (25.5%) patients infected by Beijing strain A 
of the total sample, 11 from Colon, and 2 from Panama. 
Cluster B PCR identified 1 (1.9%) patient infected by strain 
B and 2 (3.9%) patients infected by strain C; all 3 of these 
patients were from Panama province.
All the isolates not labeled as corresponding to strains 
A, B, or C by the strain-specific PCRs were genotyped by 
VNTR. None showed a pattern corresponding to the strains 
targeted (they showed differences in >3 loci). This finding 
enabled us to rule out that we could be missing some strains 
related to the clusters targeted.
We used WGS to analyze all cases (except 2 for strain 
A) captured by the ASO-PCRs to determine the network of 
relationships between the isolates (Figure 2). As expected, 
we observed lower SNP-based diversity acquired along a 
linear topology for cluster C, consistent with a sequential 
host-to-host recent-transmission nature for this cluster. In 
contrast, we found more SNPs, acquired along different 
branches, with several nonsampled nodes (median vectors, 
mv; Figure 2) for clusters A and B, more likely correspond-
ing to prevalent strains that acquired higher diversity. In 
fact, for cluster A, this diversity was also detected by MI-
RU-VNTR; 4 isolates captured by the ASO-PCR showed 
single-locus variations.
Discussion
Molecular epidemiology strategies enable us to investigate 
TB transmission dynamics in a given population. However, 
to capture a true snapshot of TB transmission, these strate-
gies require a universal, long-term fingerprinting scheme. 
In other words, it is necessary to ensure that transmission 
links are not missed because of incomplete sampling of all 
the TB cases in a complete population. Unfortunately, few 
Figure 1. PCR products for allele-
specific oligonucleotide PCRs 
for Mycobacterium tuberculosis 
cluster A, cluster B, and cluster 
C strains on a selection of 
representative strains A, B, and C 
and a selection of non-A, non-B, 
and non-C controls. Testing was 
for a simplified model to survey 
tuberculosis transmission using 
data from patients and controls 
in Panama and Colon provinces, 
Panama, 2015. A) 308-bp PCR 
product (single-nucleotide 
polymorphism [SNP] 2) for strain A 
and 400-bp and 228-bp products 
(SNP1/SNP3) for non-A strain. B) 
127-bp and 297-bp PCR products 
(SNP1/SNP4) for strain B and 
209-bp and 406-bp products 
(SNP2/SNP3) for non-B strain. C) 
307-bp and 413-bp PCR products 
(SNP3/SNP4) for cluster C strain 
and 103-bp and 207-bp products 
(SNP1/SNP2) for non-C strain. 
MW, molecular weight (100-bp 
DNA ladder).
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countries have implemented universal systematic genotyp-
ing. Many countries with more limited resources and a high 
TB prevalence can afford only fragmented molecular epi-
demiology studies based on convenience samples.
An additional concern is the recent process of substi-
tuting molecular epidemiology studies with more precise 
genomic epidemiology studies based on WGS analysis 
(4,6). If we failed to implement standard systematic molec-
ular epidemiology in many high-prevalence areas, the gap 
between low- and high-income countries would widen in 
terms of genomic epidemiology. Therefore, we must define 
new strategies to offer an alternative to fill this gap. 
In this study, we propose a model based on 4 stages: 1) 
updating the identification of strains responsible for the largest 
clusters in a population, 2) application of WGS to obtain more 
in-depth knowledge of clusters, 3) design of ASO-PCRs to 
identify specific strains, and 4) implementation of a simplified 
TB-control scheme based on targeted surveillance of predomi-
nant strains. To evaluate whether our approach could simplify 
detection of TB transmission in countries with no systematic 
molecular epidemiology programs, we applied it in Panama, 
a country with high TB-related mortality (8). No systematic 
universal genotyping is available in Panama, and the only data 
available are from studies of cases from a single clinic and of 
MDR isolates (17,18). These studies were performed before 
the recent expansion of the Panama Canal, whose socioepi-
demiologic effect (19) can be considered similar to that of the 
construction of the interoceanic railroad and the Panama Ca-
nal in the mid-19th century, when large numbers of workers 
from Africa, India, and China arrived in Panama. High rates of 
malaria- and yellow fever–related deaths were associated with 
work on the Panama Canal (20). Regarding TB, the rates of 
latent infection were higher for migrant students than for US 
students living in the canal area (21).
The first step in our model revealed an unexpectedly 
high percentage of MIRU-VNTR–clustered cases. Half of 
the cases collected in Panama and Colon provinces grouped 
into 6 clusters. Fortunately, none of these clusters corre-
sponded to resistant/MDR strains, despite the high cluster-
ing rates for MDR strains reported during 2002–2004 (17). 
Four of the 6 clusters identified in our study were respon-
sible for nearly half of all cases analyzed. 
Ours was a limited strain collection, and thus some trans-
mission links might be missing because of the limited num-
ber of samples we were able to analyze, which covered only 
1 year and 2 local settings, leading us to expect that the true 
figures for clustered cases are higher. In a previous study of a 
convenience pansusceptible M. tuberculosis strain collection 
Figure 2. Networks of relationships based on whole-genome sequencing data of prevalent clusters (A, B) and active transmission cluster (C) 
in testing of a simplified model to survey tuberculosis transmission in Panama and Colon provinces, Panama, 2015. Each dot corresponds to 
a single-nucleotide polymorphism (SNP). In panel A, when 2 isolates are included in the same box, they showed no SNPs between them; the 
isolates within boxes with different colors show mycobacterial interspersed repetitive units–variable number of tandem repeats patterns with 
single-locus variations between them. mv, median vector corresponding to nonsampled nodes; REF, reference. *Isolates from 2015 used to 
design the allele-specific oligonucleotide–PCRs; †strain identified in an additional analysis in Madrid (out of the prospective study applying the 
strain-specific PCRs in Panamá). A color version of this figure is available online (http://wwwnc.cdc.gov/EID/article/25/3/18-1593-F2.htm).
RESEARCH
512 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 25, No. 3, March 2019
from 2005 (18), only 21% (13/62) were found to be clustered. 
Direct comparisons between the figures from that study and 
our study cannot be made because of marked differences in 
genotyping approaches applied. In any case, it seems that the 
clustering snapshot is now different, possibly because our 
sampling was restricted to a more precise geographic location.
Despite the short distance (74 km) between Panama and 
Colon provinces, which are connected by the best highway in 
Panama, clusters are rich in cases from one or the other prov-
ince, thus alerting us to the epidemiologic singularities of each 
population, with some strains more restricted to specific geo-
graphic niches. This finding is especially relevant for the Bei-
jing sublineage (associated with high transmissibility), which 
seems to be better represented in Colon province.
The second step in our model focused on applying 
WGS to the MIRU-VNTR clusters. This analysis revealed 
that 2 different phenomena were co-occurring in the MI-
RU-VNTR–defined large clusters A, B, and C, as follows: 
1) recent transmission in cluster C, robustly determined by 
the low diversity identified by WGS; and 2) more SNPs in 
clusters A and B. The higher number of SNPs within clus-
ters A and B (more than the 12 SNPs accepted as a thresh-
old for inferring recent transmission from WGS data) sug-
gests that these clusters involve prevalent strains that had 
accumulated higher diversity after circulating for longer 
periods. Since it was first determined (6), the SNP-based 
threshold for recent transmission has been proven correct 
in many studies (22–25). This threshold was robust even 
in circumstances that could lead to greater accumulation of 
diversity, such as prolonged host-to-host transmission and 
the simultaneous involvement of reactivation and recent 
transmission in the same event (16).
Robustly defined MIRU-VNTR clusters corresponded 
to different magnitudes of SNP-based diversity between the 
clustered isolates; that is, clusters caused by recent trans-
mission coexisted with other clusters not associated exclu-
sively with recent transmission but with prevalent strains 
that had circulated for long periods. This observation oblig-
es us to reinterpret the load of true recent transmission in 
high-prevalence settings. According to our WGS findings, 
our initial estimation of 50.0% of cases from recent trans-
mission, which was based on MIRU-VNTR analysis, must 
be reduced. This bias in the estimation of recent transmis-
sion in MIRU-VNTR–defined clusters has been discussed 
(26–28). We also demonstrated how MIRU-VNTR failed 
to differentiate between migrants who had acquired TB by 
recent transmission after arrival in Spain from other pa-
tients who had imported TB from their country of origin 
(28). Both shared identical MIRU-VNTR patterns, and 
only WGS succeeded in differentiating them based on the 
magnitude of SNP diversity (28). From our data, it can be 
deduced that WGS is necessary in high-prevalence set-
tings to differentiate MIRU-VNTR–defined clusters that 
genuinely result from recent transmission from those with 
the involvement of long-term prevalent strains. 
Because the systematic application of WGS in low-
resource settings is not realistic, our tailored ASO-PCR 
model for targeting marker SNPs for the strains previously 
identified to be responsible for a large percentage of TB 
cases remains an affordable strategy. Our proposal recon-
ciles the high discriminatory power of WGS (targeted SNPs 
are obtained from the WGS analysis) with the low-cost and 
easy implementation of PCR-based tools. Based on the ini-
tial MIRU-VNTR analysis, application of these 3 multiplex 
ASO-PCRs would have enabled us to cover 32% of all ret-
rospective TB cases in our sample. This coverage justified 
the prospective evaluation to assess their usefulness and 
precision, the last step in the implementation of our model. 
Because our multiplex ASO-PCRs were designed based on 
WGS data from a limited size convenience sample from 
Panama and Colon provinces, the PCRs should be used 
only for surveillance in these 2 major provinces.
The limited sample of isolates obtained in 2015, which 
were used to tailor the surveillance strain-specific PCRs, 
could make the PCRs useless when moving forward be-
cause the epidemiology of TB and the composition of 
circulating strains changes over time. However, the appli-
cation in Panama of the set of 3 ASO-PCRs on the prospec-
tive samples from Panama City and Colon enabled us to 
determine the strain involved in 31.4% of the cases, a figure 
close to the 32% of the isolates belonging to the 3 surveyed 
strains in 2015. This finding suggested a rather stable com-
position of strains in this setting. 
Initially, the quality of the DNA obtained from the iso-
lates in 2015 for the fourth predominant cluster (cluster D) 
was not suitable for WGS. Just recently, the VNTR analysis 
from the 2018 isolates not belonging to the A/B/C clusters 
enabled us to identify new representative cases for this clus-
ter, which will be analyzed by WGS to tailor a new PCR to 
complete and extend the coverage of the surveillance panel.
Once our strategy has proved to be useful, a country-
wide genotyping effort will be necessary to determine highly 
transmitted strains nationwide and develop new ASO-PCR 
tools for surveillance of the entire country. The strategy will 
be evaluated periodically. It will mean updating the composi-
tion of circulating strains by MIRU-VNTR analysis as soon 
as we detect a reduction in the proportion of incident isolates 
that can be labeled by the strain-specific PCRs already im-
plemented. From the VNTR analysis, we will select the new 
clusters to be targeted, according either to their magnitude 
or to the speed in which the involved strain is transmitted. 
Three representative isolates from each cluster selected will 
be analyzed by WGS to identify the strain-specific SNPs to 
tailor new PCRs to target them. Therefore, the panel of PCRs 
applied as a surveillance tool will be constantly updated ac-
cording to the changing epidemiology of the setting.
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The networks of relationships obtained from WGS 
data of the representatives of clusters A–C captured by the 
ASO-PCRs were consistent with the different nature (ei-
ther prevalent strains A/B or recently transmitted strain C) 
of the clusters analyzed. A pattern of closely related iso-
lates (below the 12-SNP cutoff determined as similarity 
threshold) (6) distributed along a simple linear topology 
was found for cluster C. However, more complex branched 
topologies and a higher diversity between the isolates were 
observed for the prevalent clusters A and B.
A high proportion (21.5%) of patients in Colon were 
infected by the Beijing strain (strain A). This finding con-
stitutes a challenging alert for the national TB-control 
program because this lineage is involved in long-term out-
breaks, which eventually become uncontrollable. In Gran 
Canaria Island, Spain, the importation of a Beijing strain in 
the 1990s caused a major outbreak that could not be con-
trolled. Three years after importation, 27% of TB patients 
on the island were infected by this strain (29). Three de-
cades later, the strain remains highly prevalent, not only on 
the island to which it was imported but also on neighboring 
islands (30). The marked presence for the Beijing lineage in 
Colon province seems to be an emergent issue because the 
lineage accounted for only 3.7% of the cases in 2005 (18). 
Those authors raised the alert about the effect of the expan-
sion of the Panama Canal on the likely modification of the 
composition of circulating strains. Application of only 1 
of our PCRs (the one targeting the Beijing strain) would 
have enabled us to characterize half of all current newly 
diagnosed TB cases in Colon; that is, persons infected by 
a highly transmissible strain. This PCR could constitute a 
key tool for optimizing the national TB-control programs 
to avoid future uncontrollable situations, such as the one 
reported for the Canary Islands.
In summary, our study evaluated the feasibility and 
usefulness of a new model for simplifying and optimiz-
ing surveillance of transmission of TB in countries with 
no systematic molecular or genomic epidemiology pro-
gram. Preliminary MIRU-VNTR analysis alerted us to a 
high percentage (50%) of clustered TB cases and revealed 
a differential distribution of clustered cases in 2 provinces 
within Panama. Subsequent WGS analysis showed that 
some of the MIRU-VNTR clusters were the result of ac-
tive recent transmission, whereas others more likely re-
sulted from prevalent long-term strains. We applied the 
WGS data to tailor 3 ASO-PCRs, which covered most cas-
es in the population. The prospective application of only 
3 ASO-PCRs enabled us to identify the strains infecting 
31.4% of incident cases. This strategy optimized tracking 
of actively transmitted M. tuberculosis strains and capture 
of new cases involving long-term prevalent strains, thus 
making it possible to reconstruct the global phylogeny of 
their clusters. Our strategy also made it possible to identify 
the alarming presence of the Beijing sublineage in the inci-
dent cases in Colon province. A design based on a rational 
integration of MIRU-VNTR, WGS, and ASO-PCR could 
provide a new model for surveillance of TB transmission in 
countries without universal molecular/genomic epidemiol-
ogy programs.
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